Citations (39)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Johan Norman, Matilda Annerstedt, Mattias Boman & Leif Mattsson. (2010) Influence of outdoor recreation on self-rated human health: comparing three categories of Swedish recreationists. Scandinavian Journal of Forest Research 25:3, pages 234-244.
Read now
Read now
Jennifer Petrillo & John Cairns. (2008) Converting condition-specific measures into preference-based outcomes for use in economic evaluation. Expert Review of Pharmacoeconomics & Outcomes Research 8:5, pages 453-461.
Read now
Read now
Simon Dixon, Craig J Currie & Phil McEwan. (2004) Utility values for obesity and preliminary analysis of the Health Outcomes Data Repository. Expert Review of Pharmacoeconomics & Outcomes Research 4:6, pages 657-665.
Read now
Read now
Articles from other publishers (36)
Ji Young Jeong, Mamurbek Karimov, Yuldoshboy Sobirov, Olimjon Saidmamatov & Peter Marty. (2023) Conceptualization of DIANA Economy and Global RPM Analysis: Differences in Digitalization Levels of Countries. Systems 11:11, pages 544.
Crossref
Crossref
Ruvini M. Hettiarachchi, Sanjeewa Kularatna, Joshua Byrnes, Brendan Mulhern, Gang Chen & Paul A. Scuffham. (2023) Valuing the Dental Caries Utility Index in Australia. Medical Decision Making 43:7-8, pages 901-913.
Crossref
Crossref
David Posawatz, Joshua Bloom, Alison Massed, Abhishek Chatterjee, Charles Resor, Yong Zhan, Andrew Weintraub & Masashi Kawabori. (2023) Cost Utility of Transcatheter Aortic Valve Replacement: Sapien 3 Versus CoreValve Evolut R. ASAIO Journal 69:5, pages 475-482.
Crossref
Crossref
François R. Girardin, Anna Nicolet, Oriol Bestard, Carmen Lefaucheur, Klemens Budde, Fabian Halleck, Sophie Brouard, Magali Giral, Pierre-Antoine Gourraud, Béatrice Horcholle, Jean Villard, Joachim Marti & Alexandre Loupy. (2023) Immunosuppressant drugs and quality-of-life outcomes in kidney transplant recipients: An international cohort study (EU-TRAIN). Frontiers in Pharmacology 14.
Crossref
Crossref
Fitsum Sebsibe Teni, Kristina Burström, Nancy Devlin, David Parkin, Ola Rolfson, Allan Abbott, Magnus Ekström, Magnus Forssblad, Peter Fritzell, Åsa Jonsson, Mikael Landén, Michael Möller, Malin Regardt, Björn Rosengren, Marcus Schmitt-Egenolf, Johanna Vinblad & Annette W-Dahl. (2023) Experience-based health state valuation using the EQ VAS: a register-based study of the EQ-5D-3L among nine patient groups in Sweden. Health and Quality of Life Outcomes 21:1.
Crossref
Crossref
Yukako Wada, Yoshifumi Bizen & Mitsuyuki Inaba. (2023) Exploring the effects of COVID-19 on motorcycle riding patterns and its importance. Frontiers in Psychology 14.
Crossref
Crossref
Manraj N. Kaur, Jiajun Yan, Anne F. Klassen, Justin P. David, Dilshan Pieris, Manraj Sharma, Louise Bordeleau & Feng Xie. (2022) A Systematic Literature Review of Health Utility Values in Breast Cancer. Medical Decision Making 42:5, pages 704-719.
Crossref
Crossref
Robin Bruyndonckx, Joke Bilcke, Alike W. van der Velden, Xiao Li, Niel Hens, Samuel Coenen, Christopher C. Butler & Philippe Beutels. (2022) Impact of Adding Oseltamivir to Usual Care on Quality-Adjusted Life-Years During Influenza-Like Illness. Value in Health 25:2, pages 178-184.
Crossref
Crossref
Anna Rose Johnson, Ammar Asban, Melisa D. Granoff, Christine O. Kang, Bernard T. Lee, Abhishek ChatterjeeDhruv Singhal. (2021) Is Immediate Lymphatic Reconstruction Cost-effective?. Annals of Surgery 274:6, pages e581-e588.
Crossref
Crossref
Yurie Sekigami, Sydney Char, Cate Mullen, Kathryn Huber, Yu Cao, Rachel Buchsbaum, Roger Graham, Salvatore Nardello, Dhruv Singhal & Abhishek Chatterjee. (2021) Cost-Effectiveness Analysis: Lymph Node Transfer vs Lymphovenous Bypass for Breast Cancer-Related Lymphedema. Journal of the American College of Surgeons 232:6, pages 837-845.
Crossref
Crossref
Mohammad Faramarzi, Mozhgan Fardid, Reza Kaboodkhani, Mehrnoosh Emadi, Javad Shahmohammadi & Khosro Keshavarz. (2021) Economic Viability and Efficacy of Day Case Versus Inpatient Tonsillectomy in Southern Iran. Value in Health Regional Issues 24, pages 193-198.
Crossref
Crossref
Ruvini Hettiarachchi, Sanjeewa Kularatna, Joshua Byrnes, Brendan Mulhern, Gang Chen & Paul A Scuffham. (2020) Valuation study for a preference-based quality of life measure for dental caries (Dental Caries Utility Index - DCUI) among Australian adolescents - study protocol. BMJ Open 10:10, pages e038626.
Crossref
Crossref
Edward J. D. Webb, John O’Dwyer, David Meads, Paul Kind & Penny Wright. (2020) Transforming discrete choice experiment latent scale values for EQ-5D-3L using the visual analogue scale. The European Journal of Health Economics 21:5, pages 787-800.
Crossref
Crossref
Matthew R. Naunheim, Leanne GoldbergJennifer B. DaiBenjamin J. RubinsteinMark S. Courey. (2020) Measuring the impact of dysphonia on quality of life using health state preferences. The Laryngoscope 130:4.
Crossref
Crossref
Matthew R. Naunheim, Jennifer B. Dai, Benjamin J. Rubinstein, Leanne Goldberg, Alan Weinberg & Mark S. Courey. (2019) A visual analog scale for patient‐reported voice outcomes: The VAS voice. Laryngoscope Investigative Otolaryngology 5:1, pages 90-95.
Crossref
Crossref
Manish P. Mehta, Michael A. Hoffer-Hawlik, Michaela O'Connor & T. Sean Lynch. (2020) Immediate Versus Delayed Hip Arthroscopy for Femoroacetabular Impingement: An Expected Value Decision Analysis. JAAOS: Global Research and Reviews 4:12, pages e20.00206.
Crossref
Crossref
Hannah L. Bromley, Dennis Petrie, G.Bruce Mann, Carolyn Nickson, Daniel Rea & Tracy E. Roberts. (2019) Valuing the health states associated with breast cancer screening programmes: A systematic review of economic measures. Social Science & Medicine 228, pages 142-154.
Crossref
Crossref
Yvonne Anne Michel, Liv Ariane Augestad, Mathias Barra & Kim Rand. (2018) A Norwegian 15D value algorithm: proposing a new procedure to estimate 15D value algorithms. Quality of Life Research 28:5, pages 1129-1143.
Crossref
Crossref
Benedict U. Nwachukwu, Conan So, William W. Schairer, Beth E. Shubin-Stein, Sabrina M. Strickland, Daniel W. Green & Emily R. Dodwell. (2017) Economic Decision Model for First-Time Traumatic Patellar Dislocations in Adolescents. The American Journal of Sports Medicine 45:10, pages 2267-2275.
Crossref
Crossref
Amjad I. Hussain, Andrew M. Garratt, Jan Otto Beitnes, Lars Gullestad & Kjell I. Pettersen. (2015) Validity of standard gamble utilities in patients referred for aortic valve replacement. Quality of Life Research 25:7, pages 1703-1712.
Crossref
Crossref
Malin Ulfsdotter, Lene Lindberg & Anna Månsdotter. (2015) A Cost-Effectiveness Analysis of the Swedish Universal Parenting Program All Children in Focus. PLOS ONE 10:12, pages e0145201.
Crossref
Crossref
Michael Sonntag, Hans-Helmut König & Alexander Konnopka. (2015) The responsiveness of the EQ-5D and time trade-off scores in schizophrenia, affective disorders, and alcohol addiction. Health and Quality of Life Outcomes 13:1.
Crossref
Crossref
Kerstin Hogg, Joseph Shaw, Douglas Coyle, Parvaneh Fallah, Marc Carrier & Phil Wells. (2014) Validity of standard gamble estimated quality of life in acute venous thrombosis. Thrombosis Research 134:4, pages 819-825.
Crossref
Crossref
J. Shannon Swan, Chin Hur, Pablo Lee, Tina Motazedi & Karen Donelan. (2013) Responsiveness of the Testing Morbidities Index in Colonoscopy. Value in Health 16:6, pages 1046-1053.
Crossref
Crossref
J. Shannon SwanChung Yin KongJanie M. LeeOmosalewa ItaumaElkan F. HalpernPablo A. LeeSergey VavinskiyOlubunmi WilliamsEmilie S. ZoltickKaren Donelan. (2013) Patient and Societal Value Functions for the Testing Morbidities Index. Medical Decision Making 33:6, pages 819-838.
Crossref
Crossref
Dennis W Raisch, Patricia Feeney, David C GoffJrJr, KM Venkat Narayan, Patrick J O’Connor, Ping Zhang, Don G Hire & Mark D Sullivan. (2012) Baseline comparison of three health utility measures and the feeling thermometer among participants in the action to control cardiovascular risk in diabetes trial. Cardiovascular Diabetology 11:1.
Crossref
Crossref
Donna Rowen, John Brazier, Aki Tsuchiya & Mónica Hernández Alava. (2011) Valuing states from multiple measures on the same visual analogue sale: a feasibility study. Health Economics 21:6, pages 715-729.
Crossref
Crossref
Jennifer A. Whitty, Sharyn R. Rundle-Thiele & Paul A. Scuffham. (2012) Insights from Triangulation of Two Purchase Choice Elicitation Methods to Predict Social Decision Making in Healthcare. Applied Health Economics and Health Policy 10:2, pages 113-126.
Crossref
Crossref
A. Simon Pickard, Saurabh Ray, Arijit Ganguli & David Cella. (2012) Comparison of FACT- and EQ-5D–Based Utility Scores in Cancer. Value in Health 15:2, pages 305-311.
Crossref
Crossref
Antonieta Medina Lara, Barbara Nyanzi Wakholi, Agnes Kasirye, Paula Munderi, Christine Watera, David G Lalloo, Alan Haycox, Charles F Gilks & Heiner Grosskurth. (2008) Utility assessment of HIV/AIDS-related health states in HIV-infected Ugandans. AIDS 22:Suppl 1, pages S123-S130.
Crossref
Crossref
Adrian R. Levy, Kris V. Kowdley, Uchenna Iloeje, Eskinder Tafesse, Jayanti Mukherjee, Robert Gish, Natalie Bzowej & Andrew H. Briggs. (2008) The Impact of Chronic Hepatitis B on Quality of Life: A Multinational Study of Utilities from Infected and Uninfected Persons. Value in Health 11:3, pages 527-538.
Crossref
Crossref
John Brazier & Christopher McCabe. (2007) ‘Is there a case for using visual analogue scale valuations in CUA’ by Parkin and Devlin a response: ‘yes there is a case, but what does it add to ordinal data?’. Health Economics 16:6, pages 645-647.
Crossref
Crossref
Leida M Lamers, Carin A Uyl-de Groot & Ivonne Buijt. (2007) The Use of Disease-Specific Outcome Measures in Cost-Utility Analysis. PharmacoEconomics 25:7, pages 591-603.
Crossref
Crossref
Katherine J. Stevens, Christopher J. McCabe & John E. Brazier. (2006) Mapping between Visual Analogue Scale and Standard Gamble data; results from the UK Health Utilities Index 2 valuation survey. Health Economics 15:5, pages 527-533.
Crossref
Crossref
John Brazier, Ron Akehurst, Alan Brennan, Paul Dolan, Karl Claxton, Chris McCabe, Mark Sculpher & Aki Tsuchyia. (2005) Should Patients Have a Greater Role in Valuing Health States?. Applied Health Economics and Health Policy 4:4, pages 201-208.
Crossref
Crossref
Janne A Martikainen, Akseli Kivioja, Taru Hallinen & Pia Vihinen. (2005) Economic Evaluation of Temozolomide in the Treatment of Recurrent Glioblastoma Multiforme. PharmacoEconomics 23:8, pages 803-815.
Crossref
Crossref